HC Wainwright & Co. Maintains Buy on TRACON Pharma, Lowers Price Target to $3

TRACON Pharmaceuticals, Inc. -5.00%

TRACON Pharmaceuticals, Inc.




HC Wainwright & Co. analyst Edward White maintains TRACON Pharma (NASDAQ: TCON) with a Buy and lowers the price target from $6 to $3.
Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via